1 / 1

1. Measurement of the AARR = screening test

1. Measurement of the AARR = screening test. 1. Study visit. Stop of beta-blocker intake after 1. study visit 2-6 weeks interval between 1. and 2. study vist. 2. Measurement of the AARR and SIT. 2. Study visit. Primary aldosteronism. Other forms of hypertension.

dwight
Télécharger la présentation

1. Measurement of the AARR = screening test

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 1. Measurement of the AARR = screening test 1. Study visit Stop of beta-blocker intake after 1. study visit 2-6 weeks interval between 1. and 2. study vist 2. Measurement of the AARR and SIT 2. Study visit Primary aldosteronism Other forms of hypertension Diagnostic criteria for other forms of hypertension: All patients, who do not fulfil the criteria for primary aldosteronism Diagnostic criteria for primary aldosteronism: At least one AARR of ≥ 5.7 ng/dL/ng/L including an aldosterone level of ≥ 9 ng/dL plus Aldosterone concentrations of ≥ 10 ng/dL after the SIT

More Related